Recall Z-2482-2023

Oculus Optikgeraete GMBH · initiated August 8, 2023

Class II Open, Classified

Class II – products that might cause a temporary health problem or pose a slight threat of a serious nature

Product

Oculus Pentacam AXL Wave, Ref 70020, CE 0123

Codes / lots: UDI-DI; (01) 04049584025357

Reason for recall

Their is a potential that optical devices with insufficient anti-reflective coating may lead to incorrect axial length measurements.

FDA-determined cause: Process control

Action taken

On August 04, 2023, Oculus issued a Urgent Field Safety Notice" Correction via UPS Express. Oculus ask consignees to take the following actions: 1. Immediately stop using the affected devices for axis length measurement (mark the affected devices with a note) or take them out of service immediately. Devices not listed in Appendix B are not affected by this corrective action and can continue to be used according to the instructions for use. 2. Please fill out the attached form (Appendix A) and return it to OCULUS and your local OCULUS representative as soon as possible, but no later than 30 days after receipt. By completing this form, you acknowledge receipt of the Urgent Field Safety Notice and that you understand the issue and the actions required. 3. Pass this urgent safety information on to all users of the affected products and other people who need to be informed so that they are aware of the problem. Please file this letter directly with your device and make sure that it is and remains visible to all users at the storage location. It is important that the meaning of this notification is understood. 4. If you have given the products to a third party, please forward a copy of this information immediately and please inform us accordingly. 5. Please keep this urgent safety information at least until the action has been completed.

Details

Recall number
Z-2482-2023
Initiated
August 8, 2023
Posted by FDA
August 30, 2023
Product code
MXK – Device, Analysis, Anterior Segment
Quantity
143 units
Distribution
US Nationwide distribution in the states of CA, FL, MA, MN, NY, NC, OH, PA, TX, VA, WA. OUS: Not Provided
Recalling firm
Oculus Optikgeraete GMBH, Wetzlar

Official FDA recall record

Other products in the same recall event

RecallProductInitiated
Z-2483-2023 Class IIOculus Pentacam AXL , Ref 70100, CE 0123Their is a potential that optical devices with insufficient anti-reflective coating may lead to incorrect… 08/08/2023Open, Classified
Z-2484-2023 Class IIOculus Myopia Master , Ref 68100, CE 0123Their is a potential that optical devices with insufficient anti-reflective coating may lead to incorrect… 08/08/2023Open, Classified